» Articles » PMID: 37050412

Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization

Overview
Publisher MDPI
Date 2023 Apr 13
PMID 37050412
Authors
Affiliations
Soon will be listed here.
Abstract

Hydrogel is one of the most interesting and excellent candidates for oral drug delivery. The current study focuses on formulation development of hydrogels for controlled oral delivery of esomeprazole. The hydrogels were prepared by solution casting method by dissolving polymers in Polyvinyl alcohol (PVA) solution. Calcium alginate, Hydroxyl propyl methylcellulose (HPMC), acrylic acid and chondroitin sulfate were used in the preparation of hydrogels. Fourier transform infrared (FTIR) analysis showed no incompatibilities between drug and excipients used in the preparation of formulations. The hydrogels were characterized for size and surface morphology. Drug encapsulation efficiency was measured by Ultraviolet-visible (UV-VIS) spectroscopy. In vitro release studies were carried out using dissolution apparatus. The formulated hydrogels were then compared with the marketed product in vivo using rabbits. The result indicates that prepared hydrogels have a uniform size with a porous surface. The esomeprazole encapsulation efficiency of the prepared hydrogels was found to be 83.1 ± 2.16%. The esomeprazole-loaded hydrogel formulations showed optimum and Pharmacopeial acceptable range swelling behavior. The release of esomeprazole is controlled for 24 h (85.43 ± 0.32% in 24 h). The swelling and release of drug results make the prepared hydrogels a potential candidate for the controlled delivery of esomeprazole. The release of the drug from prepared hydrogel followed the super case transport-2 mechanism. The in vivo studies showed that prepared hydrogel formulations showed controlled and prolonged release of esomeprazole as compared to drug solution and marketed product. The formulations were kept for stability studies; there was no significant change observed in physical parameters, i.e., (appearance, color change and grittiness) at 40 °C ± 2/75% ± RH. There was a negligible difference in the drug content observed after the stability study suggested that all the formulations are stable under the given conditions for 60 days. The current study provides a valuable perspective on the controlled release profile of Hydroxyl propyl methylcellulose (HPMC) and calcium alginate-based esomeprazole hydrogels.

References
1.
Liu J, Pang Y, Zhang S, Cleveland C, Yin X, Booth L . Triggerable tough hydrogels for gastric resident dosage forms. Nat Commun. 2017; 8(1):124. PMC: 5527117. DOI: 10.1038/s41467-017-00144-z. View

2.
Thai H, Nguyen C, Thi Thach L, Tran M, Duc Mai H, Nguyen T . Characterization of chitosan/alginate/lovastatin nanoparticles and investigation of their toxic effects in vitro and in vivo. Sci Rep. 2020; 10(1):909. PMC: 6976711. DOI: 10.1038/s41598-020-57666-8. View

3.
Pawlowicz K, Paczkowska-Walendowska M, Osmalek T, Cielecka-Piontek J . Towards the Preparation of a Hydrogel from Lyophilisates of the Aqueous Extract. Pharmaceutics. 2022; 14(7). PMC: 9319300. DOI: 10.3390/pharmaceutics14071489. View

4.
Laverty G, Gorman S, Gilmore B . Antimicrobial peptide incorporated poly(2-hydroxyethyl methacrylate) hydrogels for the prevention of Staphylococcus epidermidis-associated biomaterial infections. J Biomed Mater Res A. 2012; 100(7):1803-14. DOI: 10.1002/jbm.a.34132. View

5.
Kumar P, Ganure A, Subudhi B, Shukla S . Preparation and characterization of pH-sensitive methyl methacrylate-g-starch/hydroxypropylated starch hydrogels: in vitro and in vivo study on release of esomeprazole magnesium. Drug Deliv Transl Res. 2015; 5(3):243-56. DOI: 10.1007/s13346-015-0221-7. View